<bill session="110" type="s" number="467" updated="2023-01-11T20:04:22Z">
  <state datetime="2007-01-31">REFERRED</state>
  <status>
    <introduced datetime="2007-01-31"/>
  </status>
  <introduced datetime="2007-01-31"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to expand the clinical trials drug data bank.</title>
    <title type="display">FACT Act</title>
    <title type="short" as="introduced">FACT Act</title>
    <title type="short" as="introduced">Fair Access to Clinical Trials Act of 2007</title>
  </titles>
  <sponsor bioguide_id="D000388"/>
  <cosponsors>
    <cosponsor bioguide_id="B000468" joined="2007-01-31"/>
    <cosponsor bioguide_id="C001035" joined="2007-05-24"/>
    <cosponsor bioguide_id="D000563" joined="2007-01-31"/>
    <cosponsor bioguide_id="G000386" joined="2007-01-31"/>
    <cosponsor bioguide_id="H000206" joined="2007-01-31"/>
    <cosponsor bioguide_id="J000177" joined="2007-06-14"/>
    <cosponsor bioguide_id="W000779" joined="2007-01-31"/>
  </cosponsors>
  <actions>
    <action datetime="2007-01-31">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2007-01-31" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S1449-1454" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Auditing"/>
    <term name="Cancer"/>
    <term name="Chemotherapy"/>
    <term name="Child health"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug advertising"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Families"/>
    <term name="Fines (Penalties)"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health information systems"/>
    <term name="Identification devices"/>
    <term name="Law"/>
    <term name="Medical research"/>
    <term name="Medical supplies"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Nonprofit organizations"/>
    <term name="Periodicals"/>
    <term name="Product safety"/>
    <term name="Research centers"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2007-03-23T14:13:35Z" status="Introduced in Senate">Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related interventions conducted to test the safety or effectiveness of any drug, biological product, or device intended to treat serious or life-threatening diseases and conditions; and (2) a clinical trial results database of health-related interventions to test the safety or effectiveness of any drug, biological product, or device.

Requires the Commissioner of Food and Drugs to make available to the public: (1) the full reviews conducted by the Food and Drug Administration (FDA) of new or supplemental new drug applications, including documentation of significant differences of opinion and the resolution of those differences; and (2) copies of written consultations on a drug's safety conducted by the Office of Surveillance and Epidemiology.

Requires the Secretary to assess civil monetary penalties for knowingly submitting inaccurate information to the FDA.

Allows the Secretary to correct any information included in the registry or database that is factually and substantively inaccurate, false, or misleading.

Extends requirements of this Act to clinical trials conducted outside of the United States under certain circumstances.

Prohibits a responsible person or a manufacturer from performing any act that prohibits, limits, or imposes unreasonable delays on the ability of an individual to discuss or publish the results of a clinical trial.

Requires the Secretary to enter into a contract with the Institute of Medicine to study the extent to which data submitted to the registry has impacted the public health.</summary>
</bill>
